Cost-Effectiveness Analysis of Empagliflozin In The Treatment Of T2d With Previous Cardiovascular Disease In Italy
Abstract
Authors
S Iannazzo E Mannucci O Reifsnider AP Maggioni
S Iannazzo E Mannucci O Reifsnider AP Maggioni
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now